𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Analysis of LRRK2 G2019S and I2020T mutations in Parkinson's disease

✍ Scribed by Monika Bialecka; Shen Hui; Gabriela Klodowska-Duda; Grzegorz Opala; Eng-King Tan; Marek Drozdzik


Book ID
116768028
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
57 KB
Volume
390
Category
Article
ISSN
0304-3940

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


G2019S LRRK2 mutation in familial and sp
✍ Sofya N. Pchelina; Andrei F. Yakimovskii; Olga N. Ivanova; Anton K. Emelianov; A πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 80 KB

## Abstract Among mutations associated with autosomal dominant and sporadic Parkinson's disease (PD) the G2019S substitution in the leucine‐rich repeat kinase 2 (LRRK2) gene is the most frequently identified. To estimate its frequency in Russia, we analyzed 208 patients with PD from the Northwester

Kin-cohort analysis of LRRK2-G2019S pene
✍ Stefano Goldwurm; Sara Tunesi; Silvana Tesei; Michela Zini; Francesca Sironi; Pa πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 1023 KB

Posterior cortical atrophy (PCA) represents a degenerative disorder characterized by the development of higherorder visual deficit. 1 PCA may result from heterogeneous pathologies that make up tauopathies. An increasing number of mutations in the tau gene (microtubule-associated protein tau [MAPT])